Identification of FDA-approved drugs that target hepatitis B virus transcription.
about
Cell Culture Models for the Investigation of Hepatitis B and D Virus InfectionDYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner.Hepatitis B Virus Protein X Induces Degradation of Talin-1.The current status and future directions of hepatitis B antiviral drug discovery.
P2860
Identification of FDA-approved drugs that target hepatitis B virus transcription.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of FDA-approved drugs that target hepatitis B virus transcription.
@en
type
label
Identification of FDA-approved drugs that target hepatitis B virus transcription.
@en
prefLabel
Identification of FDA-approved drugs that target hepatitis B virus transcription.
@en
P2093
P2860
P356
P1476
Identification of FDA-approved drugs that target hepatitis B virus transcription.
@en
P2093
H L Zaaijer
M A A van de Klundert
N A Kootstra
P2860
P304
P356
10.1111/JVH.12479
P577
2015-10-12T00:00:00Z